|
| Title |
|
|
|
Tozasertib analogues as inhibitors of necroptotic cell death
| |
| Author |
|
|
|
| |
| Abstract |
|
|
| | |
| Language |
|
|
|
English
| |
| Source (journal) |
|
|
|
Journal of medicinal chemistry. - Washington, D.C., 1963, currens | |
| Publication |
|
|
|
Washington, D.C. : 2018
| |
| ISSN |
|
|
|
0022-2623 [print]
1520-4804 [online]
| |
| Volume/pages |
|
|
|
61:5(2018), p. 1895-1920
| |
| ISI |
|
|
|
000427331500011
| |
| Pubmed ID |
|
|
|
29437386
| |
| Full text (Publisher's DOI) |
|
|
| | |
| Full text (publisher's version - intranet only) |
|
|
| | |
|
| Faculty/Department |
|
|
| | |
| Research group |
|
|
|
| Project info |
|
|
|
Identification, lead optimization and validation of necroptosis inhibitors. High-end molecular dynamics simulations combined with click chemistry synthesis to develop novel therapeutic compounds starting from small molecule fragments. Computational investigations of the catalytic mechanism of Staphylococcus aureus transglycosylase: design and chemical synthesis of novel mechanism-based inhibitors.
| Publication type |
|
|
| | | |
| Subject |
|
|
| | | |
| Affiliation |
|
|
|
Publications with a UAntwerp address
| |
|
|
|
| Identification |
|
| |
|
|
| Creation |
|
| |
19.03.2018
|
|
| Last edited |
|
| |
23.03.2020
|
|
| To cite this reference |
|
|
| | |
|
| |